Nanoveu Ltd. (AU:NVU)
ASX:NVU
Top Page
Nanoveu Ltd.
(Sydney:NVU)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.07
â–¼(-23.33% Downside)
Action:ReiteratedDate:03/02/26
The score is held down primarily by weak financial performance—deep losses, negative gross profit, and ongoing cash burn—despite relatively low recent leverage. Technicals are also soft (below key moving averages with negative MACD), with oversold indicators only partially offsetting. Valuation is constrained by a negative P/E, reflecting the lack of profitability.
Positive Factors
Specialized product niche
Nanoveu’s focus on nanotech optical and protective films targets durable, application-specific needs in electronic displays. A specialized product set can create technical differentiation, licensing or OEM partnerships, and higher-margin opportunities if products gain adoption across device manufacturers.
Negative Factors
Persistent cash burn
Consistent negative operating and free cash flow indicate the business cannot self-fund at current scale. Over 2–6 months this raises the probability of external financing, dilution risk, or constrained R&D/commercial spend, limiting the firm’s ability to scale or respond to market opportunities.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized product niche
Nanoveu’s focus on nanotech optical and protective films targets durable, application-specific needs in electronic displays. A specialized product set can create technical differentiation, licensing or OEM partnerships, and higher-margin opportunities if products gain adoption across device manufacturers.
Read all positive factors
Nanoveu Ltd. (NVU) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$65.91M
Dividend YieldN/A
Average Volume (3M)9.28M
Price to Earnings (P/E)―
Beta (1Y)2.18
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
EmployeesN/A
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,080,451,200
10 Day Avg. Volume7,199,231
30 Day Avg. Volume9,283,654
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)5.64
Price to Sales (P/S)233.13
P/FCF Ratio-11.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanoveu Ltd. Business Overview & Revenue Model
Company Description
Nanoveu Limited, a technology company, develops and sells nanotechnology applications for consumer devices in the Americas and internationally. The company provides Nanoshield, an antiviral protector, which is available in various mobile phone scr...
How the Company Makes Money
Nanoveu Ltd. generates revenue through the sale of its proprietary products and solutions. The company monetizes its technology by selling Nanoshield screen protectors directly to consumers as well as through distribution partnerships with retaile...
Nanoveu Ltd. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 297.58K | 6.87K | 102.54K | 159.51K | 781.21K |
| Gross Profit | -2.23M | 10.53K | 25.27K | 72.37K | 386.56K |
| EBITDA | -7.45M | -2.73M | -1.98M | -2.45M | -1.97M |
| Net Income | -7.42M | -2.85M | -2.16M | -2.67M | -2.32M |
Balance Sheet | |||||
| Total Assets | 13.55M | 1.32M | 513.00K | 427.33K | 2.75M |
| Cash, Cash Equivalents and Short-Term Investments | 1.81M | 498.30K | 73.07K | 248.14K | 2.01M |
| Total Debt | 341.96K | 126.33K | 225.26K | 300.00K | 986.68K |
| Total Liabilities | 1.46M | 983.58K | 622.40K | 700.75K | 1.17M |
| Stockholders Equity | 12.31M | 374.94K | -109.41K | -273.41K | 1.58M |
Cash Flow | |||||
| Free Cash Flow | -5.92M | -2.10M | -2.01M | -2.82M | -2.04M |
| Operating Cash Flow | -5.85M | -2.10M | -2.01M | -2.82M | -2.04M |
| Investing Cash Flow | -287.31K | -258.66K | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 7.44M | 2.53M | 1.83M | 142.12K | 2.91M |
Nanoveu Ltd. Technical Analysis
Negative
0.09
Price Trends
0.08
Negative
0.08
Negative
0.08
Negative
Market Momentum
>-0.01
Positive
30.55
Neutral
22.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NVU, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.08, and above the 200-day MA of 0.08, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 30.55 is Neutral, neither overbought nor oversold. The STOCH value of 22.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:NVU.
Nanoveu Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$30.75M | -173.03 | -2.31% | ― | 2.98% | 93.55% | |
48 Neutral | AU$21.85M | -3.90 | -27.05% | ― | -3.43% | -40.65% | |
43 Neutral | AU$65.91M | -9.35 | -86.31% | ― | ― | ― | |
43 Neutral | AU$1.43M | -0.06 | -562.56% | ― | ― | ― | |
43 Neutral | AU$19.81M | -13.76 | 46.05% | ― | 7.32% | 67.11% | |
41 Neutral | AU$20.74M | -3.83 | -153.09% | ― | -48.98% | -12.82% |
* Technology Sector Average
AU:NVU
Nanoveu Ltd.
0.06
0.02
50.00%
AU:1TT
Wooboard Technologies Limited
0.01
0.00
0.00%
AU:VIG
Victor Group Holdings Ltd
0.04
-0.02
-31.67%
AU:AMX
Aerometrex Ltd.
0.23
0.00
0.00%
AU:XF1
Xref Ltd
0.09
-0.05
-35.71%
AU:ICE
iCetana Ltd.
0.04
0.02
143.75%
Nanoveu Ltd. Corporate Events
Nanoveu files 2025 corporate governance statement with ASX
Feb 27, 2026
Nanoveu Limited has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 31 December 2025 is available on its website, in accordance with ASX Listing Rules. The statement, approved by the board, details t...
Nanoveu revenue surges but losses deepen in 2025 results
Feb 27, 2026
Nanoveu Limited reported a sharp increase in revenue from ordinary activities to A$298,000 for the year ended 31 December 2025, representing a 4,230% rise on the prior year. Despite this growth, the company’s net loss attributable to members...
Nanoveu Issues 56.9 Million Unquoted Options Expiring in 2029
Jan 27, 2026
Nanoveu Limited has notified the market of the issue of 56,931,835 unquoted options, each exercisable at $0.15 and expiring on 27 January 2029. The options, which form part of previously announced transactions and are not intended to be quoted on ...
Nanoveu Seeks ASX Quotation for 9.25 Million New Shares
Jan 27, 2026
Nanoveu Limited has applied to the ASX for quotation of 9,250,000 new ordinary fully paid shares under code NVU, with an issue date of 27 January 2026. The move increases the company’s quoted share capital, which may enhance liquidity in its...
Nanoveu Seeks ASX Quotation for 83.9 Million New Shares
Jan 27, 2026
Nanoveu Limited has applied for quotation on the ASX of 83,863,637 new fully paid ordinary shares, with an issue date of 27 January 2026. The additional securities, which stem from previously announced transactions, will expand the company’s...
Nanoveu Secures $7.38m in Strategic Placement and Option Exercises
Jan 27, 2026
Nanoveu Limited has completed the main tranche of its previously announced strategic placement, raising $7.38 million before costs via the issue of 83.9 million new shares at $0.088 each, accompanied by 41.9 million attaching options, within its e...
Nanoveu Plans Major Share and Option Issue to Raise Capital
Jan 19, 2026
Nanoveu Limited has notified the ASX of a proposed capital raising involving the issue of up to 85,227,274 new fully paid ordinary shares and 57,613,637 options, each with an exercise price of $0.15 and expiring in January 2029. The securities are...
Nanoveu Raises A$7.5m to Fast-Track Edge-AI Chip Commercialisation and Global Expansion
Jan 19, 2026
Nanoveu has secured firm commitments to raise A$7.5 million via an upsized share placement at A$0.088 per share, with free attaching options, from new and existing sophisticated and institutional investors, with directors also participating subjec...
Nanoveu Seeks Trading Halt Ahead of Capital Raising Announcement
Jan 15, 2026
Nanoveu Limited has requested an immediate trading halt in its securities on the ASX as it prepares to announce details of a proposed capital raising. The halt will remain in place until either the start of normal trading on 20 January 2026 or the...
Nanoveu Issues 250,000 Shares on Exercise of Unlisted Options
Jan 14, 2026
Nanoveu Limited has issued 250,000 new ordinary shares following the exercise of unlisted options, modestly expanding its share capital. The company confirmed the shares were issued without a prospectus in reliance on provisions of the Corporation...
Nanoveu Applies to List 250,000 New Ordinary Shares on ASX
Jan 14, 2026
Nanoveu Limited has applied to the ASX for the quotation of 250,000 new fully paid ordinary shares under the code NVU, with an issue date of 14 January 2026. The securities arise from the exercise or conversion of existing options or other convert...
Nanoveu Seeks ASX Quotation for Over 6 Million New Shares
Dec 24, 2025
Nanoveu Ltd has applied to the ASX for quotation of 6,026,923 new fully paid ordinary shares, to be traded under its existing ticker NVU. The new securities, issued on 24 December 2025 following the exercise or conversion of existing options or ot...
Nanoveu Expands Share Capital Through Exercise of Unlisted Options
Dec 24, 2025
Nanoveu Limited has issued 6,026,923 new ordinary shares following the exercise of unlisted options, expanding its share capital without a separate disclosure document under Australia’s Corporations Act. The company confirmed it is compliant...
Nanoveu Limited Announces Investor Webinar on EMASS SoC Advancements
Dec 16, 2025
Nanoveu Limited has announced an investor webinar to discuss the advancements of its subsidiary, EMASS, in ultra-low-power ECS-DoT system-on-chip (SoC) technologies. The webinar will highlight significant milestones such as the tape-out of a new i...
Nanoveu Advances in Edge AI with 16nm SoC Milestone
Dec 16, 2025
Nanoveu Limited’s subsidiary, Embedded A.I. Systems Pte. Ltd (EMASS), has reached a significant milestone with its 16nm ECS-DoT AIoT system-on-chip (SoC), completing the front-end, synthesis, and physical design stages. This development posi...
Nanoveu Updates ASX Announcement on Edge AI Collaboration
Dec 9, 2025
Nanoveu Limited announced an amendment to its previous ASX announcement regarding its collaboration with EMASS and Semtech on low-power edge AI. The amendment involved the removal of an incorrectly displayed Semtech logo, with no new material info...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.